ASTRO MED INC /NEW/

CIK:0000008146|SEC Filings

Condensed Consolidated Statements of Income (Loss) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2026	Apr. 30, 2025
Income Statement [Abstract]
Revenue	$ 39,364	$ 37,708
Cost of Revenue	24,939	25,757
Gross Profit	14,425	11,951
Operating Expenses:
Selling and Marketing	5,692	5,605
Research and Development	1,809	1,529
General and Administrative	5,362	4,246
Operating Expenses	12,863	11,380
Operating Income	1,562	571
Other Income (Expense):
Interest Expense	(675)	(897)
Gain (Loss) on Foreign Currency Transactions	(77)	5
Other Income (Expense), net	39	20
Total Other Income (Expense)	(713)	(872)
Income (Loss) Before Income Taxes	849	(301)
Income Tax Provision	196	75
Net Income (Loss)	$ 653	$ (376)
Net Income (Loss) per Common Share-Basic	$ 0.09	$ (0.05)
Net Income (Loss) per Common Share-Diluted	$ 0.08	$ (0.05)
Weighted Average Number of Common Shares Outstanding—Basic	7,677,974	7,559,704
Weighted Average Number of Common Shares Outstanding—Diluted	7,774,315	7,559,704

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2026	Apr. 30, 2025
Cash Flows from Operating Activities:
Net Income (Loss)	$ 653	$ (376)
Adjustments to Reconcile Net Income (Loss) to Net Cash Provided by Operating Activities:
Depreciation and Amortization	1,182	1,290
Grant Income included in Depreciation	69	56
Amortization of Debt Issuance Costs	10	8
Share-Based Compensation	389	306
Deferred Income Tax Provision (Benefit)	37	(52)
Changes in Assets and Liabilities:
Accounts Receivable	(2,691)	210
Inventories	(766)	(2,704)
Income Taxes	146	172
Accounts Payable and Accrued Expenses	3,902	3,622
Deferred Revenue	(73)	1,041
Other	163	822
Net Cash Provided by Operating Activities	3,021	4,395
Cash Flows from Investing Activities:
Purchases of Property, Plant and Equipment	(36)	(60)
Net Cash Used for Investing Activities	(36)	(60)
Cash Flows from Financing Activities:
Net Cash Proceeds from Share Purchases under Employee Stock Purchase Plan		51
Net Cash Used for Payment of Taxes Related to Vested Restricted Stock	(191)	(155)
Net Payments under Revolving Credit Facility	(824)	(2,872)
Payment of Minimum Guarantee Royalty Obligation	(423)	(428)
Principal Payments of Long-Term Debt	(809)	(826)
Net Cash Provided by Financing Activities	(2,247)	(4,230)
Effect of Exchange Rate Changes on Cash and Cash Equivalents	(135)	198
Net Increase in Cash and Cash Equivalents	603	303
Cash and Cash Equivalents, Beginning of Period	4,072	5,050
Cash and Cash Equivalents, End of Period	4,675	5,353
Supplemental Disclosures of Cash Flow Information:
Interest	652	770
Income Taxes, net of refunds	$ 50	(100)
Non-Cash Transactions:
Operating Lease Obtained in Exchange for Operating Lease Liabilities		$ 936

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Apr. 30, 2026	Jan. 31, 2026
CURRENT ASSETS
Cash and Cash Equivalents	$ 4,675	$ 4,072
Accounts Receivable, net	21,627	18,985
Inventories, net of reserves	43,926	43,252
Prepaid Expenses and Other Current Assets	4,425	4,395
Total Current Assets	74,653	70,704
Property, Plant and Equipment, net	13,646	14,128
Identifiable Intangibles, net	20,684	21,496
Goodwill	17,244	17,376
Deferred Tax Assets, net	9,780	9,831
Right of Use Asset	2,307	2,466
Other Assets	1,542	1,565
TOTAL ASSETS	139,856	137,566
CURRENT LIABILITIES
Accounts Payable	7,601	6,806
Accrued Compensation	4,673	4,390
Other Accrued Expenses	7,564	4,702
Revolving Credit Facility	15,398	16,273
Current Portion of Long-Term Debt	4,272	3,033
Current Liability—Royalty Obligation	1,233	1,656
Current Liability—Excess Royalty Payment Due	194	331
Income Taxes Payable	1,036	691
Deferred Revenue	393	489
Total Current Liabilities	42,364	38,371
NON-CURRENT LIABILITIES
Long-Term Debt, net of current portion	16,234	18,295
Lease Liabilities, net of current portion	1,784	1,953
Grant Deferred Revenue	926	899
Income Taxes Payable, net of current portion	800	800
Royalty Obligation, net of current portion	160	145
Other Long-Term Liabilities	66	241
TOTAL LIABILITIES	62,334	60,704
SHAREHOLDERS' EQUITY
Preferred Stock, $10 Par Value, Authorized 100,000 shares, None Issued
Common Stock, $0.05 Par Value, Authorized 13,000,000 shares; Issued 11,156,635 and 11,077,051 shares at April 30, 2026 and January 31, 2026, respectively	558	554
Additional Paid-in Capital	66,889	66,329
Retained Earnings	47,657	47,004
Treasury Stock, at Cost, 3,433,213 and 3,415,144 shares in April 30, 2026 and January 31, 2026, respectively	(35,418)	(35,227)
Accumulated Other Comprehensive Loss, net of tax	(2,164)	(1,798)
TOTAL SHAREHOLDERS' EQUITY	77,522	76,862
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	$ 139,856	$ 137,566